Back to the Top
Dear Friends,
what is the importance of Vd/F and Cl/F over VD and Cl, if F is not known then how to calculate these parameters.
Dr Zafar
Back to the Top
CL/F can be a very valuable parameter. By itself it does not mean much,
but if you compare two groups and you can assume equal bioavailability,
you can get some very important information about the clearance. You can
also use the same subjects and do a crossover study, which makes it even
more robust. Clearance is a model independent parameter.
Vd/F however is totally useless (or more accurately incorrect)
parameter. It will be correct only in the case when your drug can best
be described by one-compartment distribution. If we take Vbeta (or
Varea), it will be correct only if the half-life after non-IV
administration is identical to that after IV bolus administration (Vbeta
= (D*t1/2)/(AUC*ln2)). In real life you can't make that assumption.
Vss/F (Vss is the "real" volume term) is even more erroneous. After
non-IV administration the equation becomes Vss/F = CL/F*(MRTnon-IV -
MAT). You don't have the MAT because you need the MRT after IV
administration to calculate it. Remember Vss = CL * MRT. If you divide
the Vss and CL by F, it is totally legitimate, but the MRT is still the
MRT after IV administration. MRTnon-IV - MAT equals MRT after IV
administration.
We wrote a short communication of this in the J.Vet.Pharm.Therap., but I
guess nobody reads that Journal.
Best regards,
Stefan Soback, DVM, PhD
Back to the Top
The following message was posted to: PharmPK
Dr. Zafar:
CL/F and V/F are hybrid parameters. They are formally known as "apparent
oral clearance" and "apparent (oral) volume of distribution". They are
useful in the same way that CL and V are useful, ie you can use them to
develop a dosage regimen, even when F is not known. I'm sure Dr. Bourne
discusses them in his online PK text. I know Bauers text has examples of
use.
Wolowich
NSUCOP
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@lists.ucdenver.edu with "V/F and CL/F" as the subject |
Copyright 1995-2014 David W. A. Bourne (david@boomer.org)